Literature DB >> 2689140

Corticosteroids and adrenal suppression. Characterising and avoiding the problem.

E L Helfer1, L I Rose.   

Abstract

Glucocorticoids are used for a variety of illnesses. One of their major complications is suppression of the hypothalamic-pituitary-adrenal axis, rendering a patient unable to respond to stress. The risk of this suppression may be minimised by the use of short-acting glucocorticoid preparations, administration of the entire daily dose in the early morning, use of topical and intra-articular preparations where appropriate, and the use of alternate-day therapy where appropriate. Most importantly, glucocorticoids should be used cautiously when indicated, and the duration of therapy limited as much as possible.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2689140     DOI: 10.2165/00003495-198938050-00008

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  14 in total

1.  NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS.

Authors:  A L GRABER; R L NEY; W E NICHOLSON; D P ISLAND; G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1965-01       Impact factor: 5.958

2.  DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS.

Authors:  T NICHOLS; C A NUGENT; F H TYLER
Journal:  J Clin Endocrinol Metab       Date:  1965-03       Impact factor: 5.958

3.  Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections.

Authors:  D C Dale; A S Fauci; S M Wolff
Journal:  N Engl J Med       Date:  1974-11-28       Impact factor: 91.245

4.  Rapid ACTH test with plasma aldosterone levels. Improved diagnostic discrimination.

Authors:  R G Dluhy; T Himathongkam; M Greenfield
Journal:  Ann Intern Med       Date:  1974-06       Impact factor: 25.391

5.  The 48-hour adrenocorticotrophin infusion test for adrenocortical insufficiency.

Authors:  L I Rose; G H Williams; P I Jagger; D P Lauler
Journal:  Ann Intern Med       Date:  1970-07       Impact factor: 25.391

Review 6.  Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations.

Authors:  J C Melby
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

7.  Adrenocortical responsiveness after alternate-day corticosteroid therapy.

Authors:  G L Ackerman; C M Nolsn
Journal:  N Engl J Med       Date:  1968-02-22       Impact factor: 91.245

8.  Suppression of 17-hydroxycorticosteroids in plasma and urine by single and divided doses of triamcinolone.

Authors:  S D Grant; P H Forsham; V C DiRaimondo
Journal:  N Engl J Med       Date:  1965-11-18       Impact factor: 91.245

9.  Choosing corticosteroid preparations.

Authors:  L I Rose; C Saccar
Journal:  Am Fam Physician       Date:  1978-03       Impact factor: 3.292

10.  Pituitary adrenal recovery following short-term suppression with corticosteroids.

Authors:  W F Streck; D H Lockwood
Journal:  Am J Med       Date:  1979-06       Impact factor: 4.965

View more
  3 in total

Review 1.  Corticosteroids and oral surgery.

Authors:  J Bodnar
Journal:  Anesth Prog       Date:  2001

2.  Childhood Cushing's syndrome induced by betamethasone nose drops, and repeat prescriptions.

Authors:  C A Findlay; J F Macdonald; A M Wallace; N Geddes; M D Donaldson
Journal:  BMJ       Date:  1998-09-12

3.  The evolution of zebrafish RAG2 protein is required for adapting to the elevated body temperature of the higher endothermic vertebrates.

Authors:  Ao Sun; Ke Xu; Haifeng Liu; Hua Li; Yaohuang Shi; Xiaoyan Zhu; Tao Liang; Xinyue Li; Xianxia Cao; Yanhong Ji; Taijiao Jiang; Chenqi Xu; Xiaolong Liu
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.